Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/AJPLUNG.00491.2005PMID 16698853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nutrition des pancréatites aiguës

  2007cited by this paper
• Pathobiology of pulmonary hypertension.

  2007cited by this paper
• Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling

  2006cited by this paper
• Simvastatin induces caspase-independent apoptosis in LPS-activated RAW264.7 macrophage cells.

  2006cited by this paper
• Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs.

  2005cited by this paper
• Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

  2005cited by this paper
• Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.

  2005cited by this paper
• Treatment of severe pulmonary hypertension: a bradykinin receptor 2 agonist B9972 causes reduction of pulmonary artery pressure and right ventricular hypertrophy.

  2005cited by this paper
• Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality.

  2005cited by this paper
• The effects of statins on endothelium, inflammation and cardioprotection.

  2005cited by this paper
• Apoptosis and lung injury.

  2005cited by this paper
• An animal model of autoimmune emphysema.

  2005cited by this paper
• PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model

  2004cited by this paper
• Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.

  2004cited by this paper
• Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth

  2004cited by this paper
• Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis

  2004cited by this paper
• Oxidative stress in severe pulmonary hypertension.

  2004cited by this paper
• Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle Cells

  2003cited by this paper
• Therapeutic value of statins for vascular remodeling.

  2003cited by this paper
• DA-8159, a potent cGMP phosphodiesterase inhibitor, attenuates monocrotaline-induced pulmonary hypertension in rats

  2003cited by this paper
• Caveolin-1 null (-/-) mice show dramatic reductions in life span.

  2003cited by this paper
• Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

  2003cited by this paper
• Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients

  2003cited by this paper
• Peroxisome Proliferator-Activated Receptor Gamma (PPAR&ggr;) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth

  2003cited by this paper
• All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells.

  2003cited by this paper
• Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium.

  2003cited by this paper
• Statins and their role in vascular protection.

  2003cited by this paper
• Expression of human herpesvirus 8 in primary pulmonary hypertension.

  2003cited by this paper
• Stomach gas laboratory in critical care.

  2002cited by this paper
• A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.

  2002cited by this paper
• Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension

  2002cited by this paper
• Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.

  2002cited by this paper
• 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.

  2002cited by this paper
• Prostacyclin for pulmonary hypertension.

  2002cited by this paper
• Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure.

  2002cited by this paper
• Caveolin-1 Expression Enhances Endothelial Capillary Tubule Formation*

  2002cited by this paper
• 40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats.

  2001cited by this paper
• Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

  2001influential reference
• The pathobiology of pulmonary hypertension. Endothelium.

  2001cited by this paper
• HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

  2001cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.

  2000cited by this paper
• Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.

  2000cited by this paper
• HIV-Related pulmonary hypertension: analytic review of 131 cases.

  2000cited by this paper
• 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 *

  1999cited by this paper
• SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

  1999cited by this paper
• Rac Downregulates Rho Activity: Reciprocal Balance between Both Gtpases Determines Cellular Morphology and Migratory Behavior

  1999cited by this paper
• Angiogenesis Activators and Inhibitors Differentially Regulate Caveolin-1 Expression and Caveolae Formation in Vascular Endothelial Cells

  1999cited by this paper
• Rac Downregulates Rho Activity

  1999cited by this paper
• Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

  1999cited by this paper
• Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.

  1999cited by this paper
• Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.

  1999cited by this paper
• Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

  1998cited by this paper
• Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost

  1998cited by this paper
• HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.

  1997cited by this paper
• Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.

  1997cited by this paper
• Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.

  1994cited by this paper
• Prostacyclin for pulmonary hypertension.

  1980cited by this paper

• Therapeutic role of caveolin family in stem cell fate and development for management of chronic degenerative diseases: A scientometric study to an in-depth review.

  2025cites this paper
• Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats

  2024cites this paper
• Advances in the potential of nebulized inhalation for the treatment of pulmonary arterial hypertension.

  2024cites this paper
• PDK1 upregulates PINK1-mediated pulmonary endothelial cell mitophagy during hypoxia-induced pulmonary vascular remodeling

  2023cites this paper
• Lipophilic Statins Eliminate Senescent Endothelial Cells by inducing Anoikis-Related Cell Death

  2023cites this paper
• Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension

  2022cites this paper
• A narrative review of research advances in hypoxic pulmonary hypertension

  2022cites this paper
• Sugen, hypoxia and the lung circulation

  2021cites this paper
• Endothelial cells in the pathogenesis of pulmonary arterial hypertension

  2021cites this paper
• Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy

  2021cites this paper
• Animal Models of PAH and Increased Pulmonary Blood Flow

  2021cites this paper
• Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension

  2021cites this paper
• α7 Nicotinic acetylcholine receptor mediates right ventricular fibrosis and diastolic dysfunction in pulmonary hypertension

  2021cites this paper
• Differential effects of the Src family tyrosine kinases yes and fyn on lipopolysaccharide-induced lung injury in mice.

  2021cites this paper
• 15-Deoxy-Δ-12,14-prostaglandin J2 effects in vascular smooth muscle cells: Implications in vascular smooth muscle cell proliferation and contractility.

  2021cites this paper
• Beyond Thrombosis: the Role of Platelets in Pulmonary Hypertension

  2020cites this paper
• Diverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary Hypertension

  2020cites this paper
• Smooth muscle Rac1 contributes to pulmonary hypertension

  2019cites this paper
• Efficacy and safety of statin therapy in pulmonary hypertension: a systematic review and meta-analysis.

  2019cites this paper
• Hsa_circ_0046159 is involved in the development of chronic thromboembolic pulmonary hypertension

  2019cites this paper
• Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.

  2019cites this paper
• Oxidative Stress and Its Implications in the Right Ventricular Remodeling Secondary to Pulmonary Hypertension

  2019cites this paper
• Atorvastatin improves the cardiac function of rats after acute myocardial infarction through ERK1/2 pathway.

  2019cites this paper
• Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism

  2019cites this paper
• The Importance of Tyrosine Phosphorylation Control of Cellular Signaling Pathways in Respiratory Disease: pY and pY Not

  2018cites this paper
• Anti‐apoptosis endothelial cell‐secreted microRNA‐195‐5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension

  2018cites this paper
• ОЦЕНКА МАРКЁРОВ ВОСПАЛЕНИЯ И ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ НА ФОНЕ ДОСТИЖЕНИЯ ЦЕЛЕВОГО УРОВНЯ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ

  2018cites this paper
• Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension

  2018cites this paper
• The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.

  2017cites this paper
• Are statins beneficial for the treatment of pulmonary hypertension?

  2017cites this paper
• Efficacy and Safety of Statins for Pulmonary Hypertension: A Meta-Analysis of Randomised Controlled Trials.

  2017cites this paper
• Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats

  2017cites this paper
• Novel strategies for treatment of pulmonary arterial hypertension.

  2017cites this paper
• Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study

  2017cites this paper
• Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future.

  2016cites this paper
• Animal Models for the Study of Pulmonary Hypertension: Potential and Limitations

  2016cites this paper
• Differential effect of mild and severe pulmonary embolism on the rat lung transcriptome

  2016cites this paper
• Glycoprotein 130 Inhibitor Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.

  2016cites this paper
• Lung Circulation.

  2016cites this paper
• Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension.

  2016cites this paper
• Targeting the Cause, affecting the Course: Characterization and Optimization of Experimental Models for Pulmonary Arterial Hypertension

  2016influential citation
• Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials

  2016cites this paper
• Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.

  2016cites this paper
• The Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells.

  2016cites this paper
• Potential Contribution of Phenotypically Modulated Smooth Muscle Cells and Related Inflammation in the Development of Experimental Obstructive Pulmonary Vasculopathy in Rats

  2015influential citation
• Pulmonary Arterial Hypertension: A Stem Cell Hypothesis

  2015cites this paper
• Animal Models of Chronic Right Ventricular Stress and Failure

  2015cites this paper
• Simvastatin promotes alveolar epithelial cell proliferation and attenuates cigarette smoke‑induced emphysema in rats.

  2015cites this paper
• Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation.

  2015cites this paper
• Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: a comprehensive review.

  2015cites this paper
• Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.

  2015cites this paper
• Macitentan reverses early obstructive pulmonary vasculopathy in rats: early intervention in overcoming the survivin-mediated resistance to apoptosis.

  2015influential citation
• Prevention of pulmonary hypoplasia and pulmonary vascular remodeling by antenatal simvastatin treatment in nitrofen-induced congenital diaphragmatic hernia.

  2015cites this paper
• Novel investigational therapies for treating pulmonary arterial hypertension

  2015cites this paper
• Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.

  2015cites this paper
• Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases

  2015cites this paper
• Inflammatory Modulation by Statins and Heart Failure: From Pharmacological Data to Clinical Evidence

  2015cites this paper
• Bcl-2 silencing attenuates hypoxia-induced apoptosis resistance in pulmonary microvascular endothelial cells

  2015cites this paper
• Treatment of Chronic Right Heart Failure

  2015cites this paper
• Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.

  2014cites this paper
• Animal Models for PAH and Increased Pulmonary Blood Flow

  2014cites this paper
• Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.

  2014cites this paper
• Endothelial Fate Mapping in Mice With Pulmonary Hypertension

  2014cites this paper
• Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat

  2014cites this paper
• Cell Death and Repair in Lung Disease

  2014cites this paper
• COPYRIGHT PULSUS GROUP INC. – DO NOT COPY

  2013cites this paper
• The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.

  2013cites this paper
• SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction

  2013cites this paper
• Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.

  2013cites this paper
• Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial

  2013cites this paper
• Atorvastatin Suppresses Aldosterone-induced Neonatal Rat Cardiac Fibroblast Proliferation by Inhibiting ERK1/2 in the Genomic Pathway

  2013cites this paper
• Pulmonary hypertension: old targets revisited (statins, PPARs, beta-blockers).

  2013cites this paper
• Tyrosine Kinase Inhibitors in Pulmonary Arterial Hypertension: A Double-Edge Sword?

  2013cites this paper
• Metabolic Remodeling and Mitochondrial Dysfunction in Maladaptive Right Ventricular Hypertrophy Secondary to Pulmonary Arterial hypertension

  2013cites this paper
• Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin‐treated rats

  2013cites this paper
• Restoration of alveolar type II cell function contributes to simvastatin-induced attenuation of lung ischemia-reperfusion injury.

  2012cites this paper
• New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis

  2012cites this paper
• Immune and inflammatory mechanisms in pulmonary arterial hypertension.

  2012cites this paper
• The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats

  2012cites this paper
• Selective Class I Histone Deacetylase Inhibition Suppresses Hypoxia-Induced Cardiopulmonary Remodeling Through an Antiproliferative Mechanism

  2012cites this paper
• The monocrotaline model of pulmonary hypertension in perspective.

  2012cites this paper
• Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.

  2012cites this paper
• Attenuation of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats by Rosuvastatin

  2012cites this paper
• A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

  2012cites this paper
• Bioactive coatings for coronary stents: Modulation of cell proliferation by controlled release of anti-proliferative drugs

  2012cites this paper
• Severe pulmonary hypertension: The role of metabolic and endocrine disorders

  2012cites this paper
• Additive effect of Tadalafil and Simvastatin on monocrotaline-induced pulmonary hypertension rats

  2012cites this paper
• Gene expression in the right ventricle during development of pulmonary hypertension

  2011cites this paper
• Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.

  2011cites this paper
• Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model

  2011cites this paper
• Short Title: Monocrotaline Model in Perspective

  2011cites this paper
• Statin Therapy is Associated with Decreased Pulmonary Vascular Pressures in Severe COPD

  2011cites this paper
• The harmonics of rodent pulmonary hypertension models

  2011cites this paper
• Key role of the RhoA/Rho kinase system in pulmonary hypertension.

  2011cites this paper
• Mechanisms of disease: pulmonary arterial hypertension

  2011cites this paper
• Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

  2011cites this paper
• Treatment of pediatric pulmonary hypertension with simvastatin: An observational study

  2011cites this paper
• Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT

  2011cites this paper
• Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells

  2011cites this paper
• Right ventricle in pulmonary hypertension.

  2011cites this paper